Drug Trial Radar · NCT05749055
ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
252
Actual
Start
Jul 3, 2023
Primary completion
Sep 18, 2025
Study completion Sep 18, 2025
Sponsor
- Lead sponsor
- Engrail Therapeutics INCIndustry
- Sponsor type
- Industry
- First posted
- Mar 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)
Conditions
- Generalized Anxiety Disorder
Interventions
ENX-102Drug
Selective GABA-A alpha2,3,5 positive allosteric modulator
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of ENX-102 versus placebo in patients with generalized anxiety disorder (GAD)Time frame: 4 weeks
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research Phoenix
Phoenix, Arizona
Collaborative Neuroscience Research, LLC (CNS)
Garden Grove, California
Sun Valley Research Center
Imperial, California
Alliance Research
Long Beach, California
NRC Research Institute
Los Angeles, California
Excell Research, Inc.
Oceanside, California
Anderson Clinical Research
Redlands, California
California Neuroscience Research, LLC
Sherman Oaks, California
Pacific Clinical Research Management Group
Upland, California
Sunwise Clinical Research
Walnut Creek, California
Mountain View Clinical Research
Denver, Colorado
Vertex Clinical Research
Clermont, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Accel Research Sites Network - Lakeland CRU
Lakeland, Florida
Accel Research Sites Network - Maitland CRU
Maitland, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
CenExel iResearch, LLC
Savannah, Georgia
Collective Medical Research
Overland Park, Kansas
Boston Clinical Trials
Boston, Massachusetts
Precise Research Centres
Flowood, Mississippi
IMA Clinical Research
Las Vegas, Nevada
SPRI Clinical Trials, LLC
Brooklyn, New York
Neurobehavioral Research
Cedarhurst, New York
Richmond Behavioral Associates
Staten Island, New York
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
Austin Clinical Trials Partners
Austin, Texas
FutureSearch Trials of Dallas
Dallas, Texas
Baylor College of Medicine
Houston, Texas
Aim Trials
Plano, Texas
Grayline Research Center
Wichita Falls, Texas
Alpine Research Organization
Clinton, Utah
Core Clinical Research
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.